NCT07210463 - A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU) | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

November 30, 2027

Conditions

Neuromuscular AgentsPeripheral Nervous System AgentsPhysiological Effects of DrugsAcetylcholine Release InhibitorsMembrane Transport ModulatorsMolecular Mechanisms of Pharmacological ActionCholinergic AgentsNeurotransmitter AgentsincobotulinumtoxinABotulinum Toxins, Type A

Interventions

DRUG

NT 201

Clostridium Botulinum neurotoxin A (150 kiloDalton \[kD\], free of complexing proteins), powder for solution for injection.

DRUG

NT 201 Placebo

NT 201 matching-placebo.

Trial Locations (26)

14467

NOT_YET_RECRUITING

Merz Investigative Site, Potsdam

15831

NOT_YET_RECRUITING

Merz Investigative Site, Blankenfelde-Mahlow

20146

NOT_YET_RECRUITING

Merz Investigative Site, Hamburg

28001

NOT_YET_RECRUITING

Merz Investigative Site, Madrid

29354

NOT_YET_RECRUITING

Merz Investigative Site, Hamburg

31008

NOT_YET_RECRUITING

Merz Investigative Site, Pamplona

34117

NOT_YET_RECRUITING

Merz Investigative Site, Kassel

40212

RECRUITING

Merz Investigative Site, Düsseldorf

42287

NOT_YET_RECRUITING

Merz Investigative Site, Wuppertal

44793

NOT_YET_RECRUITING

Merz Investigative Site, Bochum

46010

NOT_YET_RECRUITING

Merz Investigative Site, Valencia

48317

NOT_YET_RECRUITING

Merz Investigative Site, Drensteinfurt

61381

NOT_YET_RECRUITING

Merz Investigative Site, Friedrichsdorf

80539

NOT_YET_RECRUITING

Merz Investigative Site, Munich

30-002

RECRUITING

Merz Investigative Site, Krakow

32-600

RECRUITING

Merz Investigative Site, Oświęcim

20-607

NOT_YET_RECRUITING

Merz Investigative Site, Lublin